122 related articles for article (PubMed ID: 38713010)
1. Bivalirudin Monitoring in Pediatric Ventricular Assist Device and Extracorporeal Membrane Oxygenation: Analysis of Single-Center Retrospective Cohort Data 2018-2022.
Engel ER; Perry T; Block M; Palumbo JS; Lorts A; Luchtman-Jones L
Pediatr Crit Care Med; 2024 Jul; 25(7):e328-e337. PubMed ID: 38713010
[TBL] [Abstract][Full Text] [Related]
2. Description of Bivalirudin Use for Anticoagulation in Pediatric Patients on Mechanical Circulatory Support.
Campbell CT; Diaz L; Kelly B
Ann Pharmacother; 2021 Jan; 55(1):59-64. PubMed ID: 32590908
[TBL] [Abstract][Full Text] [Related]
3. How to best monitor bivalirudin anticoagulant effect for ECMO and VAD-Comparison of four assay methods.
Teruya J; Bruzdoski K; Hensch L; Hui SR; Kostousov V
Int J Lab Hematol; 2022 Jun; 44(3):589-594. PubMed ID: 34939341
[TBL] [Abstract][Full Text] [Related]
4. Correlation between partial thromboplastin time and thromboelastography in adult critically ill patients requiring bivalirudin for extracorporeal membrane oxygenation.
Buckley MS; Benanti GE; Meckel J; Tekle LA; Gilbert B; Puebla Neira D; McNierney DA; Korkames G; Yerondopoulos M; Park A; O'Hea JA; MacLaren R
Pharmacotherapy; 2023 Mar; 43(3):196-204. PubMed ID: 36759323
[TBL] [Abstract][Full Text] [Related]
5. Monitoring bivalirudin therapy in children on extracorporeal circulatory support devices: Thromboelastometry versus routine coagulation testing.
Teruya J; Hensch L; Bruzdoski K; Adachi I; Hui SR; Kostousov V
Thromb Res; 2020 Feb; 186():54-57. PubMed ID: 31884000
[TBL] [Abstract][Full Text] [Related]
6. Bivalirudin in pediatric patients maintained on extracorporeal life support.
Nagle EL; Dager WE; Duby JJ; Roberts AJ; Kenny LE; Murthy MS; Pretzlaff RK
Pediatr Crit Care Med; 2013 May; 14(4):e182-8. PubMed ID: 23648880
[TBL] [Abstract][Full Text] [Related]
7. Use of bivalirudin for anticoagulation in pediatric extracorporeal membrane oxygenation (ECMO).
Kaushik S; Derespina KR; Chandhoke S; Shah DD; Cohen T; Shlomovich M; Medar SS; Peek GJ
Perfusion; 2023 Jan; 38(1):58-65. PubMed ID: 34318718
[TBL] [Abstract][Full Text] [Related]
8. Impact of inflammation and steroids on anti-coagulation in children supported on a ventricular assist device.
Brandewie K; Lorts A; Luchtman-Jones L; Gao Z; Geer B; Villa C; Perry T
J Artif Organs; 2024 Apr; ():. PubMed ID: 38581568
[TBL] [Abstract][Full Text] [Related]
9. Monitoring Direct Thrombin Inhibitors With Calibrated Diluted Thrombin Time vs Activated Partial Thromboplastin Time in Pediatric Patients.
Hasan RA; Pak J; Kirk CJ; Friedland-Little JM; Chandler WL
Am J Clin Pathol; 2023 Jan; 159(1):60-68. PubMed ID: 36351044
[TBL] [Abstract][Full Text] [Related]
10. Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study.
Pieri M; Agracheva N; Bonaveglio E; Greco T; De Bonis M; Covello RD; Zangrillo A; Pappalardo F
J Cardiothorac Vasc Anesth; 2013 Feb; 27(1):30-4. PubMed ID: 23036625
[TBL] [Abstract][Full Text] [Related]
11. Bivalirudin Anticoagulation Dosing Protocol for Extracorporeal Membrane Oxygenation: A Retrospective Review.
Netley J; Roy J; Greenlee J; Hart S; Todt M; Statz B
J Extra Corpor Technol; 2018 Sep; 50(3):161-166. PubMed ID: 30250342
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of intravenous direct thrombin inhibitor monitoring tests: Correlation with plasma concentrations and clinical outcomes in hospitalized patients.
Beyer JT; Lind SE; Fisher S; Trujillo TC; Wempe MF; Kiser TH
J Thromb Thrombolysis; 2020 Feb; 49(2):259-267. PubMed ID: 31559512
[TBL] [Abstract][Full Text] [Related]
13. A Review of Bivalirudin for Pediatric and Adult Mechanical Circulatory Support.
Taylor T; Campbell CT; Kelly B
Am J Cardiovasc Drugs; 2021 Jul; 21(4):395-409. PubMed ID: 33174088
[TBL] [Abstract][Full Text] [Related]
14. Bivalirudin Experience in a Heterogeneous Ventricular Assist Device Population.
Bates A; Buchholz H; Freed D; MacArthur R; PiDBorochynski T; Conway J
ASAIO J; 2020 Jun; 66(6):677-682. PubMed ID: 31567418
[TBL] [Abstract][Full Text] [Related]
15. UNBLOCK: an open-label, dose-finding, pharmacokinetic and safety study of bivalirudin in children with deep vein thrombosis.
O'Brien SH; Yee DL; Lira J; Goldenberg NA; Young G
J Thromb Haemost; 2015 Sep; 13(9):1615-22. PubMed ID: 26180006
[TBL] [Abstract][Full Text] [Related]
16. Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation.
Ranucci M; Ballotta A; Kandil H; Isgrò G; Carlucci C; Baryshnikova E; Pistuddi V;
Crit Care; 2011; 15(6):R275. PubMed ID: 22099212
[TBL] [Abstract][Full Text] [Related]
17. Chromogenic and Clot-Based Bivalirudin Assays for Monitoring Anticoagulation.
Raghavendran P; Tillman BF; Wheeler AP; Gailani D
J Appl Lab Med; 2023 Nov; 8(6):1074-1083. PubMed ID: 37811688
[TBL] [Abstract][Full Text] [Related]
18. Bivalirudin in pediatric extracorporeal membrane oxygenation.
Ryerson LM; McMichael ABV
Curr Opin Pediatr; 2022 Jun; 34(3):255-260. PubMed ID: 35634698
[TBL] [Abstract][Full Text] [Related]
19. Time in Therapeutic Range for Bivalirudin Among Pediatric Ventricular Assist Device Recipients.
Daugherty J; Heyrend C; Profsky M; Kay B; VanderPluym C; Griffiths ER; May LJ
ASAIO J; 2021 May; 67(5):588-593. PubMed ID: 32826396
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic strategies in children receiving long-term Berlin Heart EXCOR ventricular assist device therapy.
Rutledge JM; Chakravarti S; Massicotte MP; Buchholz H; Ross DB; Joashi U
J Heart Lung Transplant; 2013 May; 32(5):569-73. PubMed ID: 23465252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
